您好,欢迎您来到格朗瑞生物科技公司网站!
[登录]
[注册]
  • Content

LKT/MELANOMA-ASSOCIATED ANTIGEN PEPTIDE 1 (27-35), HUMAN/M1649/1 mg

多肽
LKT/MELANOMA-ASSOCIATED ANTIGEN PEPTIDE 1 (27-35), HUMAN/M1649/1 mg


商品编号


M1649-1 mg



品牌


LKT Labs



公司


LKT Laboratories, Inc



公司分类


Peptides



Size

1 mg

商品信息

Product ID
M1649
Cas No.
Purity
≥95%
Description
Product Info
Shipping and Storage
Downloads
References

Description
MART-1 is an endogenous melanoma-associated antigen that can be used in the development of vaccines to induce an immune response against cancerous cells expressing melanoma antigens. Vaccines using MART-1 conjugates have shown some anticancer chemotherapeutic efficacy in clinical trials.
Product Info
Purity
≥95%
Formula
C
37
H
67
N
9
O
11
Formula Wt.
814.0
Synonym
MART-1 (27-35)
Appearance
White to off white powder
Shipping and Storage
Store Temp
-20°C
Ship Temp
Ambient
Downloads
Info Sheet
M1649 Info Sheet PDF
References
Chodon T, Comin-Anduix B, Chmielowski B, et al. Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma. Clin Cancer Res. 2014 May 1;20(9):2457-65. PMID: 24634374.
Romano E, Michielin O, Voelter V, et al. MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial. J Transl Med. 2014 Apr 12;12:97. PMID: 24726012.

上一篇 LKT/MELANOMA-ASSOCIATED ANTIGEN PEPTIDE 1 (27-35), HUMAN/M1649/2 mg  下一篇 LKT/MATRIX GLA PROTEIN - PNA/M2460/10 mg

产品货号:1613.6

1613.6 ¥
11至15个工作日送达